IBA Worldwide, Hitachi, Ltd and Elekta AB are Dominating the Global Proton Therapy Market in 2020

Global Proton Therapy Market is expected to grow with the CAGR of 6.45% in the forecast period of 2021 to 2028. The years considered for study are as mentioned below.

Access Full Report @ https://www.databridgemarketresearch.com/reports/global-proton-therapy-market

Global proton therapy market is a highly consolidated market, which includes specific number of key players as well as local players. The market has witnessed increased strategic developments owing to favourable market scenario.

The major players dealing in global proton therapy market are introducing strong range of product portfolio. This helped companies to maximize the sales with enhanced product portfolio. For instance, In June, Elekta AB announced an independent organization MedTech Breakthrough which is responsible for recognizing the top companies and Service provider in the global health and medical technology market has awarded the “Medical Device Engineering Breakthrough” prize in the 2019 MedTech Breakthrough Awards program to Elekta. This will add as an achievement for the company and help them in future business expansion.

IBA Worldwide is dominating player in global proton therapy market. The other key players existing in the market includes Varian Medical Systems, Inc., Protom International, Mevion Medical Systems, Sun Nuclear Corporation, Provision Healthcare, Hitachi, Ltd., Sumitomo Heavy Industries, Ltd., Koninklijke Philips N.V., IBA Worldwide, Elekta AB, Optivus Proton Therapy, Inc., Advanced Oncotherapy, GE Healthcare (A subsidiary of General Electric Company), Best Cyclotron Systems, Inc., RaySearch Laboratories and PerMedics, Inc. among others.

Proton Therapy MarketIBA WORLDWIDE

IBA Worldwide headquartered in Louvain-La-Neuve, Belgium was founded in 1986. The company engaged in commercializing and develop innovative solutions for the diagnosis and treatment of cancer. The company offers wide range of product categories such as proton therapy, dosimetry & quality assurance, radiopharma solutions, and industrial & sterilization solutions under which proton therapy is market focused category.

For instance,

  • In September, IBA Worldwide announced that they have showcased their Future of Proton Therapy Technologies at ASTRO Annual Meeting. In this event, the company display the next technologies coming to proton therapy with a focus on motion management. After showcasing their product, the company enhanced their credibility in the market.

The company has presence in North America, Europe and Asia-Pacific. The company has various subsidiaries that are Accuray International SARL (Switzerland), Accuray Europe SAS (France), Accuray Japan K.K. (Japan), Accuray Spain, S.L.U. (Spain), Accuray Medical Equipment (India) Private Limited (India), among others

HITACHI, LTD

Hitachi, Ltd. headquartered in Tokyo, Japan was founded in year 1920. The company engaged in manufacturing and commercializing wide range of solution in different category across the world. The company offers wide range of product categories such as IT Solution, Energy Solution, Industry Solution, Mobility Solution, and Smart Life Solution under which Smart Life Solution is market focused category.

For instance,

  • In May, Hitachi, Ltd. announced that they have installed their first advanced proton therapy system to the Clínica Universidad de Navarra (Madrid, Spain). Clínica Universidad de Navarra is the first hospital where Hitachi has installed the whole proton therapy system. After this announcement, the company enhanced their business and generates adequate revenue.

The company has wide global presence across the world as Europe, North America, South America, Asia-Pacific, Middle East and Africa with its various subsidiaries such as Hitachi Construction Machinery (Japan), Hitachi High-Technologies (Japan), Hitachi Metals (Japan), Hitachi Systems (Japan), Hitachi Solutions (Japan) among others. 

Elekta AB

Elekta AB headquartered in Stockholm, Sweden, was founded in 1948. The company is engaged in offering solutions for integrated healthcare solutions and in pharma, biotech & nutrition along with specialty ingredients. The company offers wide range of product categories such as radiotherapy, stereotactic radiosurgery, mr/rt, oncology informatics, brachytherapy, neurosurgery, particle therapy which particle therapy is market focused category.

For instance,

  • In June, Elekta AB announced an independent organization MedTech Breakthrough which is responsible for recognizing the top companies and Service provider in the global health and medical technology market has awarded the “Medical Device Engineering Breakthrough” prize in the 2019 MedTech Breakthrough Awards program to Elekta. This will add as an achievement for the company and help them in future business expansion.

The company has wide global presence acrossNorth America, South America, Europe, Asia-Pacific, Middle East & Africa. The company has various subsidiaries Elekta Holdings U.S., Inc. (U.S.), Kaiku Health (Germany), Beijing Medical Equipment Institute (China), Elekta Oncology Systems, Inc. (U.S.), Elekta (U.K.), among others.